Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients
Clinical trial NCT06429839 · RECRUITING
Trial details
- NCT number
- NCT06429839
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2025-12-31
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.